諾泰生物(688076.SH)業績快報:2021年度淨利潤降7.51%至1.14億元
格隆匯2月28日丨諾泰生物(688076.SH)發佈2021年度業績快報,實現營業收入6.42億元,同比增長13.23%;歸屬於母公司所有者的淨利潤1.14億元,同比下降7.51%;歸屬於母公司所有者的扣除非經常性損益的淨利潤1.04億元,同比增加9.87%;基本每股收益0.60元。
報吿期內,影響經營業績的主要因素:1、報吿期內,公司夯實發展基礎,加強能力建設,各項業務正常有序開展。營業收入較上年同期增長13.23%。公司加強BD建設,深化與海外客户的合作關係,並積極拓展國內客户,定製產品與服務收入穩步增長。
2、報吿期內,公司歸屬於上市公司股東的淨利潤較2020年度下降7.51%,主要系:(1)公司加強能力建設,部分產能尚處於逐步達產增效過程中,公司費用水平有所提升;(2)定製類產品與服務受下游客户終端產品銷售情況、研發註冊審批進度及發貨等因素影響帶來的收入波動,引起淨利潤下降;(3)政府補貼等非經常性損益較2020年度減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.